SEC Form 4 · accession 0001902368-26-000007
Travere Therapeutics, Inc. · TVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jula Inrig
Officer — CHIEF MEDICAL OFFICER
Period of report
Jun 22, 2026
Accepted (ET)
Jun 22, 2026 · 4:37 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001438533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2026 | G | 468 | $0.00 | D | 112,770 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction represents a bona fide gift of 468 shares of common stock to a donor-advised fund. The reporting person authorized the gift on June 16, 2026, and the transfer occurred on June 22, 2026.